Mar 10, 2015Live Imaging Reveals a New Role for the Sigma-1 Receptor in Allowing Microglia to Leave Brain InjuryNeuroscience Letters 591 (2015)Christian Moritz, Francesco Berardi, Carmen Abate and Francesca PeriView Paper
Neuroscience Letters 591 (2015)Christian Moritz, Francesco Berardi, Carmen Abate and Francesca PeriView Paper
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
